Hikma Pharmaceuticals PLC (HKMPY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 09:45AM EDT. Market open.
| Previous close | 44.63 |
| Open | 44.63 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 44.63 - 44.63 |
| 52-week range | 41.08 - 75.81 |
| Volume | |
| Avg. volume | 1,209 |
| Market cap | 4.994B |
| Beta (5Y monthly) | 0.02 |
| PE ratio (TTM) | 12.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.08 (2.42%) |
| Ex-dividend date | 17 Mar 2022 |
| 1y target est | N/A |
- Business Wire
Bio-Thera Solutions and Hikma Pharmaceuticals Announce Exclusive Commercialization and License Agreement for BAT2206 in the US, a Proposed Biosimilar Referencing Stelara® (ustekinumab)
GUANGZHOU, China & LONDON, August 27, 2021--Bio-Thera Solutions and Hikma Pharmaceuticals announce exclusive commercialization and license agreement for BAT2206 in the US.
© 2022 Yahoo. All rights reserved.
